Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,327,000 | 3,275,000 | 1,315,000 | 480,000 | -1,303,000 |
| Depreciation Amortization | 2,073,000 | 1,387,000 | 696,000 | 2,767,000 | 2,074,000 |
| Income taxes - deferred | 282,000 | -377,000 | -199,000 | -1,844,000 | -1,465,000 |
| Accounts receivable | -546,000 | -213,000 | 79,000 | 139,000 | 67,000 |
| Accounts payable and accrued liabilities | -37,000 | -267,000 | -105,000 | 290,000 | 348,000 |
| Other Working Capital | -2,859,000 | -2,732,000 | -780,000 | 3,783,000 | 3,311,000 |
| Other Operating Activity | 1,452,000 | 1,511,000 | 751,000 | 5,213,000 | 4,821,000 |
| Operating Cash Flow | $6,692,000 | $2,584,000 | $1,757,000 | $10,828,000 | $7,853,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,011,000 | -1,977,000 | 0 | 2,348,000 | 2,348,000 |
| PPE Investments | -358,000 | -211,000 | -104,000 | -523,000 | -376,000 |
| Net Acquisitions | -461,000 | -294,000 | -273,000 | -4,840,000 | -4,765,000 |
| Purchase Of Investment | -119,000 | -37,000 | -16,000 | -492,000 | -453,000 |
| Other Investing Activity | -9,000 | -12,000 | -22,000 | 58,000 | 22,000 |
| Investing Cash Flow | $-2,958,000 | $-2,531,000 | $-415,000 | $-3,449,000 | $-3,224,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 3,464,000 | N/A |
| Debt Repayment | -1,780,000 | -1,771,000 | -1,762,000 | -1,970,000 | -1,963,000 |
| Common Stock Issued | 376,000 | 279,000 | 252,000 | 422,000 | 249,000 |
| Common Stock Repurchased | -1,692,000 | -1,257,000 | -730,000 | -1,150,000 | -800,000 |
| Dividend Paid | -3,009,000 | -2,004,000 | -1,010,000 | -3,918,000 | -2,945,000 |
| Other Financing Activity | -377,000 | -240,000 | -176,000 | -281,000 | -234,000 |
| Financing Cash Flow | $-6,482,000 | $-4,993,000 | $-3,426,000 | $-3,433,000 | $-5,693,000 |
| Exchange Rate Effect | 87,000 | 92,000 | 19,000 | -40,000 | 15,000 |
| Beginning Cash Position | 9,991,000 | 9,991,000 | 9,991,000 | 6,085,000 | 6,085,000 |
| End Cash Position | 7,330,000 | 5,144,000 | 7,926,000 | 9,991,000 | 5,037,000 |
| Net Cash Flow | $-2,661,000 | $-4,848,000 | $-2,065,000 | $3,906,000 | $-1,049,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,692,000 | 2,584,000 | 1,757,000 | 10,828,000 | 7,853,000 |
| Capital Expenditure | -358,000 | -211,000 | -104,000 | -523,000 | -376,000 |
| Free Cash Flow | 6,334,000 | 2,373,000 | 1,653,000 | 10,305,000 | 7,477,000 |